Press Release: CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions' Expanded Credit Facility and Syndicate to Support Acquisition of Acterys

Dow Jones
04/15
TORONTO--(BUSINESS WIRE)--April 15, 2026-- 

CIBC Innovation Banking announced today its role as Lead Arranger and Administrative Agent in an expanded credit facility for Vena Solutions (Vena), a top-tier AI-powered Microsoft-native Financial Planning and Analysis (FP&A) platform that connects data, people and agents to help customers plan better and achieve more.

The increased financing and broadened syndicate are set to support Vena's acquisition of Acterys, an industry-leading Microsoft Power BI-based operational planning and app development platform, and provide additional capital to fuel future growth for the newly combined organization. Existing investors include Vista Equity Partners, JMI Equity and Centana Growth Partners.

Having achieved Centaur status, surpassing US$100 million in annual recurring revenue, Vena continues to scale its platform and expand its presence within the Microsoft ecosystem. As part of this evolution, Vena continues to advance Vena AI, embedding intelligent AI agents directly within governed finance and operational workflows to help organizations act faster on better informed decisions using the tools their teams already know and trust.

"Our mission is to help organizations perform better and achieve more with greater clarity and confidence," said Hunter Madeley, CEO of Vena. "The addition of Acterys brings complementary operational planning, analytics and app development capabilities that reinforce our commitment to serving finance and business leaders with connected, intelligent solutions that support orchestrated planning and on-time execution in an increasingly complex business environment."

"We are thrilled to support Vena's continued momentum in the enterprise performance management space," said Adam Weiers, Managing Director, CIBC Innovation Banking. "This acquisition will enhance Vena's leadership and market position, enabling the company to deliver even greater value and innovative solutions to clients globally."

About CIBC Innovation Banking

CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across North America -- a longer track record than most banks. CIBC Innovation Banking now has over $11 billion in funds managed including life sciences, health care, cleantech companies, investors, and entrepreneurs, and has assisted over 700 venture and private equity-backed businesses over the past six and a half years. The bank operates out of 14 global locations in San Francisco, Menlo Park, New York, Toronto, London, Austin, Boston, Chicago, Seattle, Vancouver, Montreal, Atlanta, Reston, and Durham. Connect with us today to start the conversation. Innovationbanking.cibc.com

About Vena

Vena is a Microsoft-native performance management platform that orchestrates financial and operational planning, analytics and execution across Microsoft Excel, Power BI, Azure and Fabric. With a governed, AI-ready data foundation and agentic AI embedded in planning workflows, Vena helps organizations make better decisions and execute with confidence. Thousands of organizations worldwide rely on Vena to perform better and achieve more.

About Acterys

Acterys provides enterprise-grade planning, analytics and application development solutions for Microsoft Power BI, Azure and Fabric. Its modular, scalable platform empowers organizations to build connected, data-driven applications at scale. Visit Acterys.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260415565867/en/

 
    CONTACT: 

Katarina Milicevic, katarina.milicevic@cibc.com, 416-362-3458

 
 

(END) Dow Jones Newswires

April 15, 2026 07:00 ET (11:00 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10